Jury Rules In Favor of Drug-Maker in Actos Trial
(LAS VEGAS, KXNT)–A jury has ruled in favor of the Japanese drug-maker Takeda in a trial in which two elderly Las Vegas-area women sued the company, alleging its diabetes drug Actos caused their bladder cancer.
The women filed separate actions alleging Takeda failed to convey information about a cancer risk to those taking the popular medication.
Takeda said during the course of a trial in Las Vegas that 70,000 people develop bladder cancer annually.
In 2011, the Food and Drug Administration issued a safety warning that use of Actos for more than one year could be associated with an increased risk of bladder cancer.
Takeda has prevailed in four of five similar lawsuits brought in the past. The drug has been sold in the U.S. since 1999.
Bertha Triana, and Delores Cipriano had sued the company. Both were diagnosed with bladder cancer in 2012.
Cipriano was represented by noted Las Vegas attorney Robert Eglet, who has won major damage awards in the past in connection with the Hepatitis C outbreak in the Valley in 2007.